| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2022-05-16 | Atamyo Therapeutics (France) | Restructuring | ||||
| 2022-04-13 | Santhera Pharmaceuticals (CH) | chief medical officer | nomination | Rare diseases - Genetic diseases - Neuromuscular diseases - Respiratory diseases | Nomination | |
| 2022-04-06 | Catalent (USA) | biologics development and manufacturing facility currently under construction near Oxford (UK) | plant acquisition | Technology - Services | Plant acquisition | |
| 2022-03-30 | Vectivbio (Switzerland) Asahi Kasei Pharma (Japan) | apraglutide | short bowel syndrome with intestinal failure (SBS-IF), acute graft-versus-host disease (aGVHD) | licensing | Inflammatory diseases - Gastrointestinal diseases - Transplantation | Licensing agreement |
| 2022-02-23 | Recipharm (Sweden) | sterile fill and finish production capabilities in Recipharm's site in Monts, France | construction of new premises | Technology - Services | Construction of new premises | |
| 2022-01-28 | Recipharm (Sweden) | new fill finish site in Morocco | Construction of new premises | |||
| 2022-01-27 | Recipharm (Sweden) undisclosed top 10 big pharma company | vaccine | manufacturing production | Technology - Services - Infectious diseases | Production agreement | |
| 2022-01-10 | Pharmaron Beijing (China) Recipharm (Sweden) | Cramlington Site in Newcastle (UK) | plant acquisition | Technology - Services | Plant acquisition | |
| 2022-01-10 | Recipharm (Sweden) Astrea Pharma (France) | solid dose manufacturing site at Fontaine-lès-Dijon (France) | Technology - Services | Plant acquisition | ||
| 2021-10-13 | Lexeo Therapeutics (USA-NY) Fujifilm Diosynth (USA-TX) | AAV-mediated gene therapies | manufacturing bioproduction | Rare diseases - Genetic diseases -Neurodegenerative diseases - Cardiovascular diseases | Production agreement | |
| 2021-08-24 | Recipharm (Sweden) | new analytical laboratory in Bengaluru, India | opening of new premises | Technology - Services | Opening of new premises | |
| 2021-07-15 | Recipharm (Sweden) | new facility in Uttarakhand, India | construction of a production plant | Technology - Services | Construction of a production plant | |
| 2021-07-12 | Vectivbio (Switzerland) | members of the board of directors | nomination | Inflammatory diseases - Gastrointestinal diseases - Transplantation | Nomination | |
| 2021-06-01 | 20Med Therapeutics (NL) Wageningen University (NL) University of Twente (NL) | SARS-CoV-2 vaccine variants | Covid-19 | collaboration, research | Infectious diseases | Collaboration agreement |
| 2021-05-25 | Vectivbio (Switzerland) | chief medical officer chief operating officer | nomination | Nomination | ||
| 2021-05-13 | Biogen (USA - MA) Envisagenics (USA - NY) | artificial intelligence (AI)-driven RNA splicing platform, SpliceCore® | CNS diseases |
collaboration
research
|
CNS diseases - Neurological diseases - Neurodegenerative diseases | Research agreement |
| 2021-05-12 | Biogen (USA - MA) TMS Co (Japan) | TMS-007, an investigational drug for acute ischemic stroke | acute ischemic stroke | product acquisition | Cerebrovascular diseases - Cardiovascular diseases | Product acquisition |
| 2021-04-16 | Lexeo Therapeutics (USA-NY) | senior vice presidents | nomination | Rare diseases - Genetic diseases -Neurodegenerative diseases - Cardiovascular diseases | Nomination | |
| 2021-03-01 | Lexeo Therapeutics (USA-NY) Adverum Biotechnologies (USA-CA) | LX2006 | Friedreich's ataxia | licensing | Rare diseases - Neurodegenerative diseases | Licensing agreement |
| 2021-02-11 | Ensoma (USA - MA) Takeda (Japan) | five undisclosed rare diseases | licensing | Rare diseases | Licensing agreement |
